$ENVA

Fisher David sold $6.6M of ENVA

Fisher David (Executive Chairman) sold 33,060 shares of Enova International, Inc. (ENVA) at $199.05 ($6.58M total) on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fisher David
Published Jun 22, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 22, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings by the executive chairman under a pre-arranged 10b5-1 plan.

02

Market read

This is a routine insider-sale filing; it may slightly influence sentiment but is unlikely to drive a major repricing absent additional corroborating news.

03

What to watch

Traders may want to compare this sale’s size versus prior Form 4 activity and check whether multiple insiders are selling on similar schedules.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-22 after-hours; sale executed 2026-06-17.

Background

The article is an SEC Form 4 insider transaction disclosure for Enova International, Inc. (ENVA).

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova executive chairman David Fisher sold 33,060 shares in an open-market transaction at $199.0514 on 2026-06-17 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely muted unless follow-on sales accelerate or size increases materially.

Evidence & confidence

The filing is a Form 4 with a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated or larger-than-usual insider sales can still coincide with management’s view of near-term valuation risk.

Key entities

  • Enova International, Inc.

    Subject of the Form 4 insider transaction; executive chairman David Fisher sold shares under a 10b5-1 plan.

  • David Fisher

    Executive Chairman; reported open-market sale of 33,060 ENVA shares at $199.0514 on 2026-06-17.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMed

Citizens Cuts Enova’s Price Target after its Bank Deal Falls Apart

Citizens analyst David Scharf cut Enova's (NYSE:ENVA) price target to $215 from $270 after it abandoned a bank acquisition deal. Enova cited unclear standards and slow approvals. The company reaffirmed its guidance for 25% revenue growth and 30% adjusted EPS growth in Q3. For the full year, it expects 20-25% revenue growth and 30-35% adjusted EPS growth. Enova reported strong Q2 results with 22% revenue growth and 33% adjusted EPS growth. The company plans to accelerate share repurchases.

$ENVAMed

Why Enova International Stock Was Plummeting This Week

Enova International (NYSE: ENVA) withdrew applications for banking licenses, causing its stock to drop nearly 20% week-to-date. The company cited unclear authorization processes and plans to focus on its existing business. Enova reaffirmed its 2026 revenue growth forecast of 20-25% and adjusted net income per share growth of 30-35%.